2-(Adamantan-1-yl)-2-aminoacetic acid

Catalog No.: 
ACIYMX173
CAS No.: 
60256-21-5
Molecular Formula: 
C12H19NO2
Molecular Weight: 
209.29
2-(Adamantan-1-yl)-2-aminoacetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$58.00In stockInquiry
250mg95%$113.00In stockInquiry
1g95%$339.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Adamantan-1-yl)-2-aminoacetic acid
IUPAC Name2-(adamantan-1-yl)-2-aminoacetic acid
MDL No.MFCD01838120
Molecular FormulaC12H19NO2
Molecular Weight209.29
SMILESO=C(O)C(C12CC3CC(C2)CC(C3)C1)N
InChI KeyNJRFVURYVWPLKB-UHFFFAOYSA-N
SynonymAlbb-007402;IFLAB-BB F1913-0001;AKOS BC-1228;ADAMANTAN-1-YL-AMINO-ACETIC ACID;2-(1-Adamantyl)glycine;alpha-Aminotricyclo[3.3.1.13,7]decane-1-acetic acid;2-(AdaMantan-1-yl)-2-aMinoacetic acid;1-adamantyl(amino)acetic acid hydrochloride
CAS No.60256-21-5
PubChem CID3157067

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACIYMX173 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIYMX173 route product structure diagram
    ACIYMX17360256-21-5In Stock
Inquiry

2. ACIYMX173 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIYMX173 route product structure diagram
    ACIYMX17360256-21-5In Stock
Inquiry

3. ACIYMX173 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIYMX173 route product structure diagram
    ACIYMX17360256-21-5In Stock
Inquiry

Comments (0)